Previous exposure to (±) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility

Neuroscience

Volumn 136, Issue 1, 2005, Pages 43-53

  Giorgi, F S ^a   Pizzanelli, C ^a   Ferrucci, M ^a   Lazzeri, G ^a   Faetti, M ^a   Giusiani, M ^a   Pontarelli, F ^b   Busceti, C L ^b   Murri, L ^a   Fornai, F ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

14C 2 DG; Ecstasy; EEG synchronization; Epilepsy; Kainate; Limbic epilepsy

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CARBON 14; DEOXYGLUCOSE; GLUTAMIC ACID; KAINIC ACID; MONOAMINE; BIOGENIC AMINE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; CONTROLLED STUDY; CONVULSION; DRUG ABUSE; DRUG EXPOSURE; ELECTROENCEPHALOGRAM; EXCITOTOXICITY; FACILITATION; LIMBIC SYSTEM; LONG TERM POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE PREDISPOSITION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURE;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; DISEASE SUSCEPTIBILITY; ELECTROENCEPHALOGRAPHY; GLUCOSE; KAINIC ACID; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED C57BL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SEIZURES;

EID: 26944444296     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.07.036     Document Type: Article

References (46)

1. S.F. Ali, L.W. Chang, W. Slikker Jr Biogenic amines as biomarkers for neurotoxicity Biomed Environ Sci 4 1991 207 216
2. R. Ben-Abraham, O. Szold, V. Rudick, A.A. Weinbroum "Ecstasy" intoxication life-threatening manifestations and resuscitative measures in the intensive care setting Eur J Emerg Med 10 2003 309 313
3. T.J. Beveridge, A.O. Mechan, M. Sprakes, Q. Pei, T.S. Zetterstrom, A.R. Green, J.M. Elliott Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain Psychopharmacology (Berl) 173 2004 346 352
4. S. Bhattachary, J.H. Powell Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or "ecstasy" evidence for cognitive impairment Psychol Med 3 2001 647 658
5. K.I. Bolla, U.D. McCann, G.A. Ricaurte Memory impairment in abstinent MDMA ("ecstasy") users Neurology 51 1998 1532 1537
6. J.L. Cadet, B. Ladenheim, H. Hirata, R.B. Rothman, S. Ali, E. Carlson, C. Epstein, T.H. Moran Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA) evidence from using CuZn-superoxide dismutase transgenic mice Synapse 21 1995 169 176
7. M.I. Colado, J. Camarero, A.O. Mechan, V. Sanchez, B. Esteban, J.M. Elliott, A.R. Green A study of the mechanisms involved in the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) on dopamine neurons in mouse brain Br J Pharmacol 134 2001 1711 1723
8. J.W. Cooley, J.W. Tukey An algorithm for the machine calculation of complex Fourier series Math Comput 19 1965 297 301
9. R.I. Dafters, F. Duffy, P.J. O'Donnell, C. Bouquet Level of use of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in humans correlates with EEG power and coherence Psychopharmacology (Berl) 145 1999 82 90
10. R. de la Torre, M. Farre Neurotoxicity of MDMA (ecstasy) the limitations of scaling from animals to humans Trends Pharmacol Sci 25 2004 505 508
11. D.S. Dinner Effect of sleep on epilepsy J Clin Neurophysiol 19 2002 504 513
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) at Luxembourg (2001) Annual Report on the State-of-the-Drug Problem in the European Union 2001 1 52
13. F. Fornai, L. Bassi, N.T. Torracca, M.G. Alessandrí, V. Scalori, G.U. Corsini Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents Neurodegeneration 5 1996 241 249
14. F. Fornai, L. Bassi, M. Gesi, F.S. Giorgi, R. Guerrini, I. Bonaccorsi, M.G. Alessandrí Similar increases in extracellular lactic acid in the limbic system during epileptic and/or olfactory stimulations Neuroscience 97 2000 447 458
15. F. Fornai, F.S. Giorgi, M. Gesi, K. Chen, M.G. Alessandrí, J.C. Shih Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice Synapse 39 2001 213 221
16. F. Fornai, M. Gesi, P. Lenzi, M. Ferrucci, G. Lazzeri, C. Pizzanelli, A. Pellegrini, G. Battaglia, S. Ruggieri, A. Paparelli Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry Ann N Y Acad Sci 1025 2004 181 188
17. F. Fornai, P. Lenzi, G. Frenzilli, M. Gesi, M. Ferrucci, G. Lazzeri, F. Biagioni, M. Nigro, A. Falleni, M. Giusiani, A. Pellegrini, Blandini, S. Ruggieri, Paparelli DNA damage and ubiquinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy) Psychopharmacology 173 2004 353 363
18. K.B.J. Franklin, G. Paxinos The mouse brain in stereotaxic coordinates 1996 Academic Press San Diego
19. K. Gale Progression and generalization of seizure discharge anatomical and neurochemical substrates Epilepsia 29 Suppl 2 1988 15 34
20. A. Gamma, E. Frei, D. Lehmann, R.D. Pascual-Marqui, D. Hell, F.X. Vollenweider Mood state and brain electric activity in ecstasy users Neuroreport 11 2000 157 162
21. F.S. Giorgi, M. Ferrucci, G. Lazzeri, C. Pizzanelli, P. Lenzi, M.G. Alessandrl, L. Murri, F. Fornai A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus Eur J Neurosci 17 2003 2593 2601
22. F.S. Giorgi, C. Pizzanelli, F. Biagioni, L. Murri, F. Fornai The role of norepinephrine in epilepsy from the bench to the bedside Neurosci Biobehav Rev 28 2004 507 524
23. J.L. Glowinski, S.D. Iversen Regional studies of catecholamines in the rat brain. I. The disposition of 3H norepinephrine, 3H dopamine and 3H DOPA in various regions of the brain J Neurochem 13 1966 655 699
24. A. Handforth, R.F. Ackermann Mapping of limbic seizure progressions utilizing the electrogenic status epilepticus model and the 14C-2-deoxyglucose method Brain Res Brain Res Rev 20 1995 1 23
25. L.K. Heisler, H.M. Chu, L.H. Tecott Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice Ann N Y Acad Sci 861 1998 74 78
26. Y. Itzhak, S.F. Ali, C.N. Achat, K.L. Anderson Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice Psychopharmacology (Berl) 166 2003 241 248
27. H. Kalant The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs CMAJ 165 2001 917 928
28. M.J. Landry MDMA a review of epidemiologic data J Psychoactive Drugs 34 2002 163 169
29. B.J. Logan, R. Laverty, W.D. Sandrson, Y.B. Yee Differences between rats and mice in MDMA (methylenedioxymethamphetamine) neurotoxicity Eur J Pharmacol 152 1988 227 234
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
31. G.M. McKhann, H.J. Wenzel, C.A. Robbins, A.A. Sosunov, P.A. Schwartzkroin Mouse strain differences in kainic acid sensitivity, seizure behaviour, mortality, and hippocampal pathology Neuroscience 122 2003 551 561
32. M. Mendez, R.A. Radtke Interactions between sleep and epilepsy J Clin Neurophysiol 18 2001 106 127
33. S. Moyano, D. Frechilla, J. Del Rio NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment a mechanism for learning impairment Psychopharmacology (Berl) 173 2004 337 345
34. J. Obrocki, R. Buchert, O. Vaterlein, R. Thomasius, W. Beyer, T. Schiemann Ecstasy-long-term effects on the human central nervous system revealed by positron emission tomography Br J Psychiatry 175 1999 186 188
35. A. Pasini, A. Tortorella, K. Gale The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin Brain Res 724 1996 84 88
36. L. Quate, D.E. McBean, I.M. Ritchie, H.J. Olverman, P.A. Kelly Acute methylenedioxymethamphetamine administration effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat Psychopharmacology (Berl) 173 2004 287 295
37. R.J. Racine Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalogr Clin Neurophysiol 32 1972 281 294
38. J. Sharkey, D.E. McBean, P.A. Kelly Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("ecstasy") Psychopharmacology (Berl) 105 1991 113 118
39. Y. Shirayama, K. Hashimoto, M. Iyo, K. Watanabe, T. Higuchi, Y. Minabe 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain pharmacological manipulation Eur J Pharmacol 402 2000 215 222
40. L. Sokoloff, M. Reivich, C. Kennedy, M.H. Des Rosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, M. Shinohara The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 1977 897 916
41. M.S. Starr The role of dopamine in epilepsy Synapse 22 1996 159 194
42. C.P. Stephenson, G.E. Hunt, A.N. Topple, I.S. McGregor The distribution of 3,4-methylenedioxymethamphetamine "ecstasy"-induced c-fos expression in rat brain Neuroscience 92 1999 1011 1023
43. D.M. Stone, G.R. Hanson, J.W. Gibb Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats Neuropharmacology 26 1987 1657 1661
44. R. Torta, F. Monaco Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy pharmacodynamic considerations Epilepsia 43 S2 2002 8 13
45. G. Wilkerson, E.D. London Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat Neuropharmacology 28 1989 1129 1138
46. P.G. Zagnoni, C. Albano Psychostimulants and epilepsy Epilepsia 43 Suppl 2 2002 28 31